结合塞图西马布和免疫疗法治疗MSS/pMMR结肠直肠癌:当前证据和挑战
Bo Pei1,2, Shixuan Peng3, Weiwei Chen4
1Department of Oncology, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi, China.
Technology in cancer research & treatment
|May 7, 2025
概括
与免疫检查点抑制剂 (ICI) 结合的塞图西马布在治疗微卫星稳定 (MSS) 大肠直肠癌 (CRC) 方面表现有前途. 需要进一步的试验来证实这种免疫治疗方法对于MSS/pMMRCRC患者.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胃肠病学 胃肠病学
背景情况:
- 结肠直肠癌 (CRC) 构成了全球严重的健康负担.
- 大多数CRC患者具有微卫星稳定 (MSS) 和熟练不匹配修复 (pMMR) 瘤.
- 这些MSS/pMMR瘤通常对免疫检查点抑制剂 (ICI) 具有抗性.
研究的目的:
- 探索将 cetuximab 与 MSS/pMMR CRC.ICI 结合在一起的潜力.
- 调查这种组合是否可以克服对免疫疗法的内在抗性.
- 评估 cetuximab 和 ICI 在 MSS/pMMR CRC 中的协同效应.
主要方法:
- 关于 cetuximab 和 ICI 组合的临床前和临床数据的审查.
- 分析 cetuximab 的免疫调节特性.
- 评估补充性治疗机制.
主要成果:
- 塞图西马布是一种向EGFR的抗体,具有免疫调节特性.
- 组合疗法可以协同增强反应率和耐久性.
- 临床前和早期临床数据表明有希望的结果.
结论:
- 将 cetuximab 与 ICI 结合在一起是 MSS/pMMR CRC.的潜在策略.
- 进一步的大规模,随机的III期试验是必不可少的.
- 目前正在进行的试验将澄清这种组合在CRC个性化免疫治疗中的作用.
关键词:
欧洲农业基金会 (EGFR) 是一个.在MSS/pMMR中使用.这就是 cetuximab 的意思.结肠直肠癌是什么意思组合疗法治疗组合治疗.免疫检查点抑制剂 免疫检查点抑制剂这些机制的机制.电阻的电阻是指电阻的电阻更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.8K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
相关概念视频
01:27Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K